MD3290436T2 - Proteină fără fenilalanină pentru tratamentul fenilcetonuriei - Google Patents

Proteină fără fenilalanină pentru tratamentul fenilcetonuriei

Info

Publication number
MD3290436T2
MD3290436T2 MDE20180783T MD3290436T2 MD 3290436 T2 MD3290436 T2 MD 3290436T2 MD E20180783 T MDE20180783 T MD E20180783T MD 3290436 T2 MD3290436 T2 MD 3290436T2
Authority
MD
Moldova
Prior art keywords
protein
phenylalanine
pku
treatment
dietary
Prior art date
Application number
Other languages
English (en)
Inventor
Bernhard Hoffmann
Yvonne Mucke
Stefan Rasche
Natalia Jablonka
Stefan Schillberg
Original Assignee
Metax Inst Fur Diatetik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metax Inst Fur Diatetik Gmbh filed Critical Metax Inst Fur Diatetik Gmbh
Publication of MD3290436T2 publication Critical patent/MD3290436T2/ro

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/54Proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Soy Sauces And Products Related Thereto (AREA)

Abstract

Invenţia se referă la o proteină dietetică recombinantă, care nu conţine fenilalanină şi este o proteină dietetică cu o valoare biologică ridicată. Sunt furnizate în continuare un vector care codifică respectiva proteină dietetică, un microorganism care exprimă respectiva proteină, o metodă pentru producerea respectivei proteine şi o compoziţie dietetică cuprinzând respectiva proteină care, într-o formă de realizare, este utilizată ca medicament şi / sau aliment pentru scopuri medicale speciale la pacienţii cu acumulări de fenilalanină în organism.
MDE20180783 2016-09-01 2016-09-01 Proteină fără fenilalanină pentru tratamentul fenilcetonuriei MD3290436T2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16186895.5A EP3290436B1 (en) 2016-09-01 2016-09-01 Phenylalanine-free protein for the treatment of pku

Publications (1)

Publication Number Publication Date
MD3290436T2 true MD3290436T2 (ro) 2019-10-31

Family

ID=56883591

Family Applications (1)

Application Number Title Priority Date Filing Date
MDE20180783 MD3290436T2 (ro) 2016-09-01 2016-09-01 Proteină fără fenilalanină pentru tratamentul fenilcetonuriei

Country Status (27)

Country Link
US (1) US10640538B2 (ro)
EP (1) EP3290436B1 (ro)
JP (1) JP6954676B2 (ro)
CN (1) CN109661401B (ro)
AU (1) AU2017317652B2 (ro)
BR (1) BR112019004270A2 (ro)
CA (1) CA3033271C (ro)
CY (1) CY1121886T1 (ro)
DK (1) DK3290436T3 (ro)
ES (1) ES2742175T3 (ro)
HR (1) HRP20191406T1 (ro)
HU (1) HUE044665T2 (ro)
IL (1) IL265015B2 (ro)
LT (1) LT3290436T (ro)
MA (1) MA43352B1 (ro)
MD (1) MD3290436T2 (ro)
ME (1) ME03510B (ro)
MX (1) MX2019002422A (ro)
NZ (1) NZ750498A (ro)
PL (1) PL3290436T3 (ro)
PT (1) PT3290436T (ro)
RU (1) RU2764796C2 (ro)
SA (1) SA519401175B1 (ro)
SI (1) SI3290436T1 (ro)
UA (1) UA124630C2 (ro)
WO (1) WO2018041920A1 (ro)
ZA (1) ZA201901505B (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113264988B (zh) * 2019-09-27 2022-12-06 湖北康肽药业有限公司 一组特殊膳食蛋白质
CN110747218A (zh) * 2019-09-27 2020-02-04 深圳市诺维健生物技术有限责任公司 一种特殊膳食蛋白质的生产方法与应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04126051A (ja) * 1990-09-18 1992-04-27 Snow Brand Milk Prod Co Ltd フェニルケトン尿症患者用栄養調製物
GB9310472D0 (en) 1993-05-20 1993-07-07 Univ Warwick Phenylalanine-free protein and dna coding thereof
GB9314802D0 (en) * 1993-07-16 1993-08-25 Pharmaceutical Proteins Ltd Modified proteins
WO1996017064A1 (en) 1994-12-02 1996-06-06 Indiana University Foundation Phenylalanine free proteins
EP1092769B1 (de) * 1999-10-15 2008-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden
AU2002234561B2 (en) * 2000-12-07 2007-01-18 Dsm Ip Assets B.V. Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
US9034402B2 (en) * 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
KR101530395B1 (ko) 2007-04-27 2015-06-19 피페넥스 인크. 향상된 수율 및(또는) 품질로 이종 단백질을 발현하는 특정 균주를 동정하기 위해 미생물 숙주를 신속히 스크리닝하는 방법
US20100316623A1 (en) * 2009-04-23 2010-12-16 Andrew Turner Phenylalanine hydroxylase fusion protein and methods for treating phenylketonuria
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
EP2831097A4 (en) 2012-03-26 2016-01-20 Pronutria Inc NUTRIENT PROTEINS AND FRAGMENTS COMPRISING LITTLE OR NO PHENYLALANINE AND METHODS
CA2892021A1 (en) 2012-11-20 2014-05-30 Pronutria, Inc. Engineered secreted proteins and methods
EP3197472B1 (en) 2014-09-22 2021-08-04 Tanea Medical AB Recombinant phe-free proteins for use in the treatment of phenylketonuria

Also Published As

Publication number Publication date
JP6954676B2 (ja) 2021-10-27
BR112019004270A2 (pt) 2019-06-04
ES2742175T3 (es) 2020-02-13
IL265015B2 (en) 2024-08-01
AU2017317652A1 (en) 2019-02-28
UA124630C2 (uk) 2021-10-20
US20190202872A1 (en) 2019-07-04
MA43352B1 (fr) 2019-08-30
WO2018041920A1 (en) 2018-03-08
IL265015B1 (en) 2024-04-01
AU2017317652B2 (en) 2020-11-19
CY1121886T1 (el) 2020-10-14
DK3290436T3 (da) 2019-08-19
IL265015A (ro) 2019-04-30
HRP20191406T1 (hr) 2019-11-15
MX2019002422A (es) 2019-07-04
NZ750498A (en) 2023-01-27
JP2019533988A (ja) 2019-11-28
EP3290436A1 (en) 2018-03-07
CN109661401A (zh) 2019-04-19
HUE044665T2 (hu) 2019-11-28
RU2019109142A3 (ro) 2021-01-27
SA519401175B1 (ar) 2022-01-08
US10640538B2 (en) 2020-05-05
CN109661401B (zh) 2023-12-19
MA43352A (fr) 2018-03-07
EP3290436B1 (en) 2019-06-05
ZA201901505B (en) 2020-08-26
SI3290436T1 (sl) 2019-11-29
RU2764796C2 (ru) 2022-01-21
PT3290436T (pt) 2019-08-30
CA3033271A1 (en) 2018-03-08
CA3033271C (en) 2024-04-02
PL3290436T3 (pl) 2020-01-31
RU2019109142A (ru) 2020-10-01
LT3290436T (lt) 2019-10-10
ME03510B (me) 2020-04-20

Similar Documents

Publication Publication Date Title
MX2019011215A (es) Ácidos nucleicos que codifican proteínas asociadas a crispr y usos de los mismos.
MX2018014573A (es) Vacuna contra el virus del zika.
MX2017010576A (es) Maltooligosacaridos ricos en fibra que tienen baja biodisponibilidad de glucosa, procedimiento de fabricacion de los mismos y uso de los mismos en alimentos para humanos y piensos para animales.
WO2017200659A3 (en) A method to enhance wound healing using silk-derived protein
EP3747457A3 (en) Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseases
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
MX2018004616A (es) Cosmetica qie tiene bacterias probioticas.
EA202191753A1 (ru) Синтетические и рекомбинантно полученные коллагеновые пептиды, имеющие биологическую активность
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX2018008644A (es) Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
MX2022003758A (es) Composiciones para el cuidado bucal que comprenden acido beta de lupulo y aminoacido.
AU2018326364A1 (en) Methods of enhancing and/or stabilizing cardiac function in patients with Fabry disease
MX2017008454A (es) Peptidos y su uso en el tratamiento de la piel.
CR20220249A (es) Derivados terapéuticos de interleucina-22
MX2017011169A (es) Uso de citrato ferrico en el tratamiento de anemia por deficiencia de hierro.
WO2017121646A8 (en) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
MX2018008643A (es) Derivados de 3-((hetero)aril)-8-amino-2-oxo-1,3-diaza-espiro-[4.5] -decano.
MD3290436T2 (ro) Proteină fără fenilalanină pentru tratamentul fenilcetonuriei
WO2018060528A3 (en) Therapeutic protein
MX2017001433A (es) Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana.
WO2014045065A3 (en) Dietary compositions and their uses
MX2016002359A (es) Suplemento antienvejecimiento.
Ricco et al. Statement from the European Society of Vascular Surgery and the World Federation of Vascular Surgery Societies: Transatlantic Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC)
WO2019040459A3 (en) Composition and nutritional supplement made therefrom
WO2019150050A8 (fr) Dimères de variants du facteur x